Showing results (481-490 of 5,925) with videos related to

Sort By:
Pageof 593
The Prostate|February 17, 2006
IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivoJanet Rubin, Xian Fan, Jill Rahnert, et al.
The Prostate|February 24, 2006
Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer modelHelena Dzojic, Angelica Loskog, Thomas H Tötterman, et al.
The Prostate|January 1, 1992
The prognostic value of histological grading and mean nuclear volume in human prostatic cancerK Nielsen, G H Berild, E Bruun, et al.
The Prostate|January 21, 2006
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF)Thomas Schwaab, Christopher P G Tretter, Jennifer J Gibson, et al.
The Prostate|March 1, 1996
Expression of CD44 isoforms in human prostate tumor cell linesJ W Stevens, P L Palechek, T L Griebling, et al.
The Prostate|March 1, 1996
Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysisB A Evans, M E Harper, C E Daniells, et al.
The Prostate|March 1, 1996
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cellsM V Cronauer, H Klocker, H Talasz, et al.
The Prostate|March 1, 1996
Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetateM Esquenet, J V Swinnen, W Heyns, et al.
The Prostate|October 1, 1996
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study GroupA Radlmaier, H U Eickenberg, M S Fletcher, et al.
The Prostate|October 1, 1996
Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatmentP Lindström, A Bergh, I Holm, et al.
Pageof 593